Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-11-006721
Filing Date
2011-07-28
Accepted
2011-07-28 17:24:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2204964z424b5.htm 424B5 391510
2 G82449.JPG g82449.jpg GRAPHIC 21665
3 G18203.JPG g18203.jpg GRAPHIC 57132
  Complete submission text file 0001047469-11-006721.txt   501417
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-174597 | Film No.: 11994678
SIC: 2836 Biological Products, (No Diagnostic Substances)